Michael D. Prados, MD

Neuro-oncologist

Dr. Michael D. Prados is a neuro-oncologist with more than 25 years of experience in treating and supervising the care of adults and children with brain tumors.

Prados' research focuses on evaluating potential treatments and treatment strategies for primary brain tumors, tumors that start in the brain instead of spreading to the brain from other parts of the body. He is co-leader of a UCSF research project dedicated to finding new treatments for pediatric brain tumors. He is also a project leader for the Pacific Pediatric Neuro-Oncology Consortium, a national association of 18 major academic centers that he founded in 2012 to pursue the same goal.

Prados earned his medical degree from Louisiana State University, where he also completed a residency in internal medicine. Later, he completed a fellowship in neuro-oncology at UCSF and joined the faculty in neurological surgery, where he currently holds the Charles B. Wilson, MD, Endowed Chair in Neurological Surgery.

For 15 years, Prados led the North American Brain Tumor Consortium, which sought new treatments for adults with tumors of the central nervous system. He was also principal investigator for the Pediatric Brain Tumor Consortium for more than a decade.

Prados is a member of the American College of Physicians, American Society of Clinical Oncology and Children's Oncology Group. He serves on the editorial boards for several medical journals and has published more than 300 articles since 1985. In 2014, he received the Victor Levin Award for lifetime excellence in clinical research from the Society for Neuro-Oncology.

Clinics

Brain Tumor Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday, 8 a.m. - 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Michael D. Prados

Education

Louisiana State University School of Medicine 1974

Residencies

Louisiana State University Health Sciences Center, Internal Medicine 1977

Fellowships

UCSF Medical Center, Neuro-Oncology 1987

Selected Research and Publications

  1. Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, MacDonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW. Prospective Feasibility and Safety Assessment of Surgical Biopsy for Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma. Neuro Oncol. 2018 May 05.
  2. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 Apr 05.
  3. Ellingson BM, Aftab DT, Schwab GM, Hessel C, Harris RJ, Woodworth DC, Leu K, Chakhoyan A, Raymond C, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Wen PY, Cloughesy TF. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Neuro Oncol. 2018 Apr 05.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.